Inhibikase Therapeutics (IKT) null Earnings

4DecConfirmed
Mar 20
Jul 20
Q2 2020
Dec 20
-0.19
-0.13
-0.06
0

Details

Expected EPS
0
Actual EPS
-0.08
Surprise EPS
-0.08
Surprise Percent
+∞%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.08 per share for .

0 Comments

Share your thoughts